Osteonecrosis of the jaw in patient with denosumab therapy

被引：0

作者：

Olate, Sergio ^{[1
,2
,3
]}

Uribe, Francisca ^{[1
,2
,4
]}

Martinez, Felipe ^{[1
,2
]}

Almeida, Andres ^{[1
,2
]}

Unibazo, Alejandro ^{[1
,2
,5
]}

机构：

[1] Univ La Frontera, Div Oral & Maxillofacial Surg, Temuco, Chile

[2] Univ La Frontera, CIMA Grp, Temuco, Chile

[3] Univ Autonoma Chile, Ctr Biomed Res, Santiago, Chile

[4] Univ La Frontera, Programa Doctorado Ciencias Med, Temuco, Chile

[5] Univ La Frontera, Programa Magister Ciencias Odontol, Temuco, Chile

来源：

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2014年 / 7卷 / 10期

关键词：

Denosumab; osteonecrosis; cancer therapy;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Osteonecrosis (ON) of the jaw has previously been linked to the use of biphosphonates; however, new drugs, also shown similar conditions. This article presents a female patient with mandibular ON related to the use of denosumab. The 55-year-old presented with bone exposure with 8 months of evolution after a dental extraction. The patient began subcutaneous injections of 60 mg denosumab four months prior to the extraction and the lesion remained after the procedure. The patient, with 14 months of follow-up, show mandible ON with no favorable evolution. The clinical condition is presented and the literature of ON associated with denosumab is discussed.

引用

页码：3707 / 3709

页数：3

共 50 条

[31] Teriparatide Therapy for Osteonecrosis of the Jaw
Chtioui, Haithem
Lamine, Faiza
Daghfous, Riadh
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (11): : 1081 - 1082
[32] Alendronic acid/denosumab interactionInteraction (first report) leading to osteonecrosis of the jaw in an elderly patient: case report
[J]. Reactions Weekly, 2010, 1310 (1) : 9 - 9
[33] Osteonecrosis of the jaw and bevacizumab therapy
Catherine Van Poznak
[J]. Breast Cancer Research and Treatment, 2010, 122 : 189 - 191
[34] Osteonecrosis of the jaw under bisphosphonate therapy - A German register for patients with osteonecrosis of the jaw
Jung, T. I.
von der Gablentz, J.
Felsenberg, D.
Hoffmeister, B.
Mundlos, S.
Amling, M.
Fratz, P.
Seibel, M. J.
[J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S65 - S65
[35] Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report
Diniz-Freitas, Marcio
Fernandez-Feijoo, Javier
Dios, Pedro Diz
Pousa, Xiana
Limeres, Jacobo
[J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2018, 45 (05) : 570 - 577
[36] Photobiomodulation and antimicrobial photodynamic therapy for the prevention of osteonecrosis of the jaw in an oncologic patient
Martins, Fabiana
Macedo, Debora
Palma, Luiz Felipe
Ortega, Karem L.
Campos, Luana
[J]. PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 36
[37] Osteonecrosis of the jaw under biphosphonate therapy - A German register for patients with osteonecrosis of the jaw
Jung, T. I.
von der Gablentz, J.
Felsenberg, D.
Hoffmeister, B.
Mundlos, S.
Amling, M.
Fratzl, P.
Seibel, M. J.
[J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S8 - S8
[38] Osteonecrosis of jaw under bisphosphonate therapy: Patient profile and risk assessment
Jung, T. I.
von der Gablentz, J.
Hoffmeister, B.
Mundlos, S.
Fratzl, P.
Amling, M.
Seibel, M. J.
Felsenberg, D.
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S113 - S113
[39] Oral bisphosphonate therapy and osteonecrosis of the jaw: What to tell the concerned patient
Koka, Sreenivas
Clarke, Bart L.
Amin, Shreyasee
Gertz, Morie
Ruggiero, Salvatore L.
[J]. INTERNATIONAL JOURNAL OF PROSTHODONTICS, 2007, 20 (02) : 115 - 122
[40] Denosumab, an alternative to bisphosphonates but also associated with osteonecrosis of the jaw — what is the risk?
[J]. British Dental Journal, 2015, 219 (3) : 117 - 117

← 1 2 3 4 5 →